FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381251710> ?p ?o ?g. }

• W4381251710 endingPage "134" @default.
• W4381251710 startingPage "124" @default.
• W4381251710 abstract "Micro RNAs (miRNAs) are small nucleic acids and they are non-coding type of RNA, which are composed of 19-25 nucleotides and work as significant post-transcriptional gene controls of multiple biological roles. Commonly, miRNAs negatively control gene expression by adhering to their particular messenger RNAs in which they generally bind to the 3'-UTR (UN translated region) of their target mRNAs and repress protein production by destabilizing the mRNA and translational silencing. (mRNAs), for both mRNA degeneration or translational restraint, depending on the level of their complementation with target its mRNA chains. Unusual expression of those miRNAs was found to be associated etiologically with several diseases such as breast carcinoma. Diverse cellular pathways involved in breast cancer is developing such as cell proliferation, apoptosis,metastasis, chemoresistance, and cancer recurrence which are controlled by the oncogenic miRNA (oncomiR) or suppressor miRNA for tumor (tsmiR). In the present study, the representation levels of miR-571 and miR-20a, the most two studied miRNAs in breast cancer, were estimated in 40 breast cancer patients at Hiwa Hospital, Sulaimani city. Real-Time-Reverse Transcription-PCR (RT-PCR) was applied to evaluate the expression of miR-571 and miR-20a. The clinical data including breast cancer with different grades, a cancer patient with chemotherapy state ( pre-chemotherapy), and ( post-chemotherapy) conditions. Results exhibited that both miR-571 and miR-20a expression is correlated with disease stage among patients taking chemotherapy. According to the results, chemotherapy increased the expression of miR-571, but reduced the expression of miR-20a in patients with breast cancer. We also found that chemotherapy had more effect on miR-571 expression in comparison with miR-20a. Furthermore, the effect of chemotherapy was higher in the early stages of breast cancer in comparison to other disease stages. In the coclusionusing both miR-571 and miR-20a as important biomarkers for detecting the the beneficial effects of chemotherapy on breast cancer." @default.
• W4381251710 created "2023-06-20" @default.
• W4381251710 creator A5060928969 @default.
• W4381251710 creator A5062473595 @default.
• W4381251710 date "2022-01-01" @default.
• W4381251710 modified "2023-09-27" @default.
• W4381251710 title "Expression of miR-571 and miR-20a in Breast Cancer Patients as Diagnostic Biomarkers" @default.
• W4381251710 doi "https://doi.org/10.33899/mjn.2022.171438" @default.
• W4381251710 hasPublicationYear "2022" @default.
• W4381251710 type Work @default.
• W4381251710 citedByCount "0" @default.
• W4381251710 crossrefType "journal-article" @default.
• W4381251710 hasAuthorship W4381251710A5060928969 @default.
• W4381251710 hasAuthorship W4381251710A5062473595 @default.
• W4381251710 hasBestOaLocation W43812517101 @default.
• W4381251710 hasConcept C104317684 @default.
• W4381251710 hasConcept C105580179 @default.
• W4381251710 hasConcept C119056186 @default.
• W4381251710 hasConcept C121608353 @default.
• W4381251710 hasConcept C145059251 @default.
• W4381251710 hasConcept C150194340 @default.
• W4381251710 hasConcept C2776694085 @default.
• W4381251710 hasConcept C2779013556 @default.
• W4381251710 hasConcept C39845236 @default.
• W4381251710 hasConcept C502942594 @default.
• W4381251710 hasConcept C530470458 @default.
• W4381251710 hasConcept C54355233 @default.
• W4381251710 hasConcept C86803240 @default.
• W4381251710 hasConceptScore W4381251710C104317684 @default.
• W4381251710 hasConceptScore W4381251710C105580179 @default.
• W4381251710 hasConceptScore W4381251710C119056186 @default.
• W4381251710 hasConceptScore W4381251710C121608353 @default.
• W4381251710 hasConceptScore W4381251710C145059251 @default.
• W4381251710 hasConceptScore W4381251710C150194340 @default.
• W4381251710 hasConceptScore W4381251710C2776694085 @default.
• W4381251710 hasConceptScore W4381251710C2779013556 @default.
• W4381251710 hasConceptScore W4381251710C39845236 @default.
• W4381251710 hasConceptScore W4381251710C502942594 @default.
• W4381251710 hasConceptScore W4381251710C530470458 @default.
• W4381251710 hasConceptScore W4381251710C54355233 @default.
• W4381251710 hasConceptScore W4381251710C86803240 @default.
• W4381251710 hasIssue "1" @default.
• W4381251710 hasLocation W43812517101 @default.
• W4381251710 hasOpenAccess W4381251710 @default.
• W4381251710 hasPrimaryLocation W43812517101 @default.
• W4381251710 hasRelatedWork W1897095351 @default.
• W4381251710 hasRelatedWork W1975859778 @default.
• W4381251710 hasRelatedWork W2021619487 @default.
• W4381251710 hasRelatedWork W2024594909 @default.
• W4381251710 hasRelatedWork W2129266710 @default.
• W4381251710 hasRelatedWork W2149771650 @default.
• W4381251710 hasRelatedWork W2153381693 @default.
• W4381251710 hasRelatedWork W2351066333 @default.
• W4381251710 hasRelatedWork W2763237291 @default.
• W4381251710 hasRelatedWork W3156831054 @default.
• W4381251710 hasVolume "10" @default.
• W4381251710 isParatext "false" @default.
• W4381251710 isRetracted "false" @default.
• W4381251710 workType "article" @default.